A detailed history of Pale Fire Capital Se transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Pale Fire Capital Se holds 52,985 shares of BDTX stock, worth $115,507. This represents 0.04% of its overall portfolio holdings.

Number of Shares
52,985
Previous 39,000 35.86%
Holding current value
$115,507
Previous $182 Million 26.82%
% of portfolio
0.04%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.2 - $6.58 $58,737 - $92,021
13,985 Added 35.86%
52,985 $230 Million
Q2 2024

Aug 13, 2024

BUY
$4.65 - $7.39 $24,658 - $39,189
5,303 Added 15.74%
39,000 $182 Million
Q1 2024

May 14, 2024

SELL
$2.67 - $5.74 $46,466 - $99,893
-17,403 Reduced 34.06%
33,697 $171 Million
Q4 2023

Feb 13, 2024

BUY
$1.77 - $3.03 $90,447 - $154,833
51,100 New
51,100 $144 Million

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $79.2M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Pale Fire Capital Se Portfolio

Follow Pale Fire Capital Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

News

Stay updated on Pale Fire Capital Se with notifications on news.